SanjalHimanshuDesaiMD

PubMed

• Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
  Sanjal H Desai, Michael A Spinner, Andrew M Evens, Alice Sykorova, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacues Azzi, Vaishalee P Kenkre, Che...> ;Blood Advances. 2023 Dec 12
• 3 citations
  Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of re...
  Charlotte B Wagner, Ken Boucher, Adrienne Nedved, Ivana N Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M Sigmund, David A B...> ;Haematologica. 2023 Nov 1
• 5 citations
  Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
  Sanjal H Desai, Michael A Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P Kenkre, Sally Arai, Cheryl Ch...> ;American Journal of Hematology. 2023 Mar 1
• Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis.
  Sanjal H Desai, Raphael Mwangi, Rebecca L King, Matthew J Maurer, James R Cerhan, Andrew L Feldman, Umar Farooq, Eric Mou, Thomas M Habermann, Carrie A Thompson, Yucai...> ;Blood Advances. 2022 Dec 27
• 1 citations
  Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
  Sanjal H Desai, Raphael Mwangi, Alexandra N Smith, Matthew J Maurer, Umar Farooq, Rebecca L King, James R Cerhan, Andrew L Feldman, Thomas M Habermann, Carrie A Thomps...> ;Hematological Oncology. 2023 Feb 1
• 1 citations
  PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
  Sanjal H Desai, Levi Pederson, Betsy LaPlant, Raphael Mwangi, Matthew Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew Feldma...> ;Blood Cancer Journal. 2022 May 3
• 2 citations
  Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from fol...
  Sanjal Desai, Betsy LaPlant, William R. Macon, Rebecca L. King, Yucai Wang, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansel...> ;Blood Cancer Journal. 2021 Sep 25
• 2 citations
  Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell Lymphoma.
  Sanjal Desai, Mansi Chaturvedi, Rumaisa Hameed, Valentina Baez-Sosa, Aarthi Shenoy> ;The Oncologist. 2021 Sep 1
• 1 citations
  Ibritumomab Tiuxetan Radioimmunotherapy for Primary Gastrointestinal Follicular Lymphoma.
  Sanjal Desai, Muhamad Alhaj Moustafa, Gregory A. Wiseman, Thomas E. Witzig> ;The Oncologist. 2021 Jul 21
• 9 citations
  Artificial intelligence in inflammatory bowel disease endoscopy: current landscape and the road ahead.
  Suneha Sundaram, Tenzin Choden, Mark Mattar, Sanjal Desai, Madhav Desai> ;Therapeutic Advances in Gastrointestinal Endoscopy. 2021 Jul 14
• Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.
  , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia & Lymphoma. 2021 Mar 2
• 3 citations
  Future directions in Hodgkin lymphoma: checkpoint inhibitors and beyond.
  Sanjal Desai, Stephen M. Ansell> ;Leukemia & Lymphoma. 2021 Feb 18
• 1 citations
  Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma.
  Sanjal H. Desai, Valentina Baez-Sosa, Rumaisa Hameed, Ghassan Al-Shbool, Stephen Fernandez, Anusha Vakiti, Facundo E. Stingo, Tripti Adhikari, Emily Paku, Vera Malkovs...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Feb 1
• 4 citations
  Lymphoma survivors have an increased long-term risk of chronic kidney disease
  Sanjal H. Desai, Ghassan Al-Shbool, Sameer Desale, Judith H. Veis, Vera Malkovska> ;Leukemia & Lymphoma. 2020 Jul 11
• 12 citations
  Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors.
  Christopher Pleyer, Clare Sun, Sanjal Desai, Inhye E. Ahn, Xin Tian, Pia Nierman, Susan Soto, Jeanine Superata, Janet Valdez, Jennifer Lotter> ;Leukemia & Lymphoma. 2020 Jun 6
• 13 citations
  Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
  Sanjal Desai, Chul Kim, Irina Veytsman> ;Current Oncology Reports. 2019 Aug 13
• 53 citations
  Management of post-transplant lymphoproliferative disorders
  Christin B. DeStefano, Sanjal H. Desai, Aarthi Shenoy, Joseph P. Catlett> ;British Journal of Haematology. 2018 Aug 1
• Join now to see all

Abstracts/Posters

• Prevalence of Chronic Kidney Disease (CKD) in Lymphoma Survivors
  Sanjal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas
  Sanjal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019